|
Baseline (T1) |
Weekly (until T3) |
Mid-Treatment (Session 9 (T2) |
End of treatment (Session 18) (T3) |
6-month Follow-up (T4) | |
|---|---|---|---|---|---|
| Demographics: age, gender, education, location etc | X | ||||
| Illness characteristics: duration, symptoms | X | ||||
| Wait time to commence FBT | X | ||||
| Resource use in HE: Hospital admissions (number and duration) | X | X | X | X | |
| Young Person | |||||
| Weight (% mBMI) | X | X | X | X | X |
| Eating Disorder Examination (EDE) | X | X | X | X | |
| Eating Disorder Examination – Questionnaire (EDE-Q) | X | X | X | X | |
| Clinical Impact Assessment (CIA) | X | X | X | X | |
| Compulsive Exercise Test (CET) | X | X | X | ||
| Family Assessment Device (FAD) | X | X | X | X | |
| Revised Children’s Anxiety and Depression Scale (RCADS) | X | X | X | X | |
| Rosenberg Self Esteem Scale | X | X | X | X | |
| EQ-5D-5L or EQ-5D-Y | X | X | X | X | |
| Ongoing treatment post T3 | X | ||||
| Evaluation of treatment | X | ||||
| Parents/Guardians | |||||
| Family Assessment Device (FAD) | X | X | X | X | |
| Parents Versus Anorexia Scale (PVA) | X | 2, 4, 6 | X | X | |
| Parent Eating Disorder Examination (PEDE) | X | X | X | X | |
| Parent Eating Disorder Examination – Questionnaire (PEDE-Q) | X | X | X | X | |
| Revised Children’s Anxiety and Depression Scale (RCADS) - Parent | X | X | X | X | |
| EQ-5D-5L | X | X | X | X | |
| Evaluation of treatment | X | ||||
| Siblings/Other Family Members | |||||
| Family Assessment Device (FAD) | X | X | X | X | |
| Evaluation of treatment | X | ||||
| EQ-5D-5L or EQ-5D-Y | X | X | X | X | |
| Therapist | |||||
| Session attendance | X | ||||
| Evaluation of treatment acceptability and feasibility | X | ||||
| Additional Health Economic Assessments | |||||
| Healthcare resources used by young people with AN (completing a purpose-built cost questionnaire) | X | X | X | X | |
| Non-healthcare costs incurred by young people with AN and their parents/siblings | X | X | X | X | |
| Resources used for implementation of the FBT telemedicine intervention | X | ||||